skip to content National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Skip to subnavigation.
Programs & Resources
skip sub-navigation, go to content.
Chemopreventive Agent Development Research Group

Funding Opportunities

This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.

Requests For Applications (RFAs)

None current.

Program Announcements


Cancer Prevention Research Small Grant Program (R03) >>> Learn more
PA Number:PAR-08-055
Release Date:December 17, 2007
Application Receipt Date(s):March 19, 2008; July 18, 2008; December 19, 2008; March 20, 2009; July 17, 2009; December 18, 2009; March 19, 2010; July 19, 2010; December 09, 2010.
Expiration Date:December 10, 2010

Quick-Trials for Novel Cancer Therapies and Prevention: Exploratory Grants (R21) >>> Learn more
PA Number:PAR-08-025
Release Date:November 19, 2007
Application Submission/Receipt Date(s):March 7, 2008; July 9, 2008; November 7, 2008; March 9, 2009; July 9, 2009; November 9, 2009; March 9, 2010; July 9, 2010; November 9, 2010.
Expiration Date:November 10, 2010


Additional Funding Opportunities Resources


The Rapid Access to Preventive Intervention Development (RAPID) Program makes the contract resources from NCI's Division of Cancer Prevention available to academic and academically-affiliated investigators for preclinical and early clinical drug development. RAPID objectives are to:

  • assist expeditious movement of novel molecules and compounds from the laboratory through Phase 1 clinical trials
  • assist investigators who submit successful requests by providing any, or all, of the preclinical and phase 1 clinical developmental requirements needed to move forward into phase 2 clinical efficacy trials
  • support further development of the chemoprevention field
  • develop prerequisites for filing IND applications to initiate clinical trials
  • provide material for proof of principle clinical testing